Chief medical officer, SanBio
Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD
The chief medical officer at SanBio discussed how the investigational agent SB623 is being studied in TBI and stroke, with future planned studies in Alzheimer disease.
Restoring Function in TBI with Stem Cell Therapy: Bijan Nejadnik, MD
The chief medical officer at SanBio discussed how the investigational agent SB623 can fill the void of disease-modifying therapies for TBI.
CMSC Live: 2025 Annual Meeting Day 3
NeurologyLive® Friday 5 — May 30, 2025
Neuroscience at AHN Saint Vincent: Advanced Treatments and Collaborative Care Closer to Home
Pregnancy Outcomes in Ofatumumab-Treated Women Appear Consistent With General Population Rates